39581-21-0Relevant academic research and scientific papers
Two cyanopyridinone-capped 9,9′-bifluorenylidene derivatives as non-fullerene acceptors for organic photovoltaic cells
Wei, Chengjin,Zhang, Tong,Zhao, Yuling,Zhou, Yang,Hailin, Ma,Yu, Tianzhi
, p. 7637 - 7646 (2021)
Two new cyanopyridinone-capped 9,9′-bifluorenylidene derivatives, 5,5′,5′′,5′′′-(([9,9′-bifluorenylidene]-3,3′,6,6′-tetrayltetrakis(4-hexylthiophene-5,2-diyl))tetrakis(methanylylidene)) tetrakis(1-butyl-4-methyl-2,6-dioxo-1,2,5,6-tetrahydropyridine-3-carbonitrile) (A1) and 5,5′,5′′,5′′′-(([9,9′-bifluorenylidene]-2,2′,7,7′-tetrayltetrakis(4-octylthiophene-5,2-diyl))tetrakis (methanylylidene))tetrakis(1-(2-ethylhexyl)-4-methyl-2,6-dioxo-1,2,5,6-tetrahydropyridine-3-carbonitrile) (A2), were synthesized as non-fullerene small molecular acceptors for organic solar cells. The compounds exhibited excellent solubility in a variety of common organic solvents such as dichloromethane, toluene and o-dichlorobenzene due to possessing different length alkyl chains on the thiophene-bridged groups and the cyanopyridinone units. The introduction of the strong electron-withdrawing cyanopyridinone groups as the capping groups can improve the intramolecular charge transfer (ICT) and thus broaden the absorption spectra of the molecules. By changing the connection points of the capping groups in the 9,9′-bifluorenylidene core, the photophysical and electrochemical properties of the compounds can be easily adjusted. The photovoltaic performance of A1 and A2 as acceptors was investigated by fabricating solar cells with the following structure: ITO/PEDOT:PSS/PBDB-T:A1(or A2)/PDTNO/Al. The results showed that power conversion efficiencies (PCEs) of 1.01% and 1.98% were obtained using A1 and A2, respectively, as the acceptors without any treatment. After treating the active layers with solvent vapor annealing, their PCEs were increased to 1.28% and 2.94%, respectively. This journal is
Readily functionalized AAA-DDD triply hydrogen-bonded motifs
Tong, Feng,Linares-Mendez, Iamnica J.,Han, Yi-Fei,Wisner, James A.,Wang, Hong-Bo
, p. 2947 - 2954 (2018)
Herein we present a new, readily functionalized AAA-DDD hydrogen bond array. A novel AAA monomeric unit (3a-b) was obtained from a two-step synthetic procedure starting with 2-aminonicotinaldehyde via microwave radiation (overall yield of 52-66%). 1H NMR and fluorescence spectroscopy confirmed the complexation event with a calculated association constant of 1.57 × 107 M-1. Likewise, the usefulness of this triple hydrogen bond motif in supramolecular polymerization was demonstrated through viscosity measurements in a crosslinked supramolecular alternating copolymer.
ATOP dyes. Optimization of a multifunctional merocyanine chromophore for high refractive index modulation in photorefractive materials
Wuerthner,Yao,Schilling,Wortmann,Redi-Abshiro,Mecher,Gallego-Gomez,Meerholz
, p. 2810 - 2824 (2001)
This paper reports synthesis, characterization and structural optimization of amino-thienyl-dioxocyano-pyridine (ATOP) chromophores toward a multifunctional amorphous material with unprecedented photorefractive performance. The structural (dynamic NMR, XRD) and electronic (UV/vis, electrooptical absorption, Kerr effect measurements) characterization of the ATOP chromophore revealed a cyanine-type π-conjugated system with an intense and narrow absorption band (εmax = 140 000 L mol-1 cm-1), high polarizability anisotropy (δα0 = 55 × 10-40 C V-1 m2), and a large dipole moment (13 D). This combination of molecular electronic properties is a prerequisite for strong electrooptical response in photorefractive materials with low glass-transition temperature (Tg). Other important materials-related properties such as compatibility with the photoconducting poly(N-vinylcarbazole) (PVK) host matrix, low melting point, low Tg, and film-forming capabilities were optimized by variation of four different alkyl substituents attached to the ATOP core. A morphologically stable PVK-based composite containing 40 wt % of ATOP-3 showed an excellent photorefractive response characterized by a refractive index modulation of Δn ≈ 0.007 and a gain coefficient of Γ ≈ 180 cm-1 at a moderate electrical field strength of E = 35 V μm-1. Even larger effects were observed with thin amorphous films consisting of the pure glass-forming dye ATOP-4 (Tg = 16 °C) and 1 wt % of the photosensitizer 2,4,7-trinitro-9-fluorenylidene-malononitrile (TNFM). This material showed complete internal diffraction at a field strength of only E = 10 V μm-1 and Δn reached 0.01 at only E = 22 V μm-1 without addition of any specific photoconductor.
Synthesis, cytotoxic characterization, and SAR study of imidazo[1,2-b]pyrazole-7-carboxamides
Demjén, András,Alf?ldi, Róbert,Angyal, Anikó,Gyuris, Márió,Hackler, László,Szebeni, Gábor J.,W?lfling, János,Puskás, László G.,Kanizsai, Iván
, (2018/07/13)
The synthesis and in vitro cytotoxic characteristics of new imidazo[1,2-b]pyrazole-7-carboxamides were investigated. Following a hit-to-lead optimization exploiting 2D and 3D cultures of MCF-7 human breast, 4T1 mammary gland, and HL-60 human promyelocytic leukemia cancer cell lines, a 67-membered library was constructed and the structure–activity relationship (SAR) was determined. Seven synthesized analogues exhibited sub-micromolar activities, from which compound 63 exerted the most significant potency with a remarkable HL-60 sensitivity (IC50 = 0.183 μM).
Design of a novel thiophene inhibitor of 15-lipoxygenase-1 with both anti-inflammatory and neuroprotective properties
Eleftheriadis, Nikolaos,Poelman, Hessel,Leus, Niek G.J.,Honrath, Birgit,Neochoritis, Constantinos G.,Dolga, Amalia,D?mling, Alexander,Dekker, Frank J.
, p. 786 - 801 (2016/08/30)
The enzyme 15-lipoxygenase-1 (15-LOX-1) plays a dual role in diseases with an inflammatory component. On one hand 15-LOX-1 plays a role in pro-inflammatory gene expression and on the other hand it has been shown to be involved in central nervous system (CNS) disorders by its ability to mediate oxidative stress and damage of mitochondrial membranes under hypoxic conditions. In order to further explore applications in the CNS, novel 15-LOX-1 inhibitors with favorable physicochemical properties need to be developed. Here, we present Substitution Oriented Screening (SOS) in combination with Multi Component Chemistry (MCR) as an effective strategy to identify a diversely substituted small heterocyclic inhibitors for 15-LOX-1, denoted ThioLox, with physicochemical properties superior to previously identified inhibitors. Ex?vivo biological evaluation in precision-cut lung slices (PCLS) showed inhibition of pro-inflammatory gene expression and in?vitro studies on neuronal HT-22?cells showed a strong protection against glutamate toxicity for this 15-LOX-1 inhibitor. This provides a novel approach to identify novel small with favorable physicochemical properties for exploring 15-LOX-1 as a drug target in inflammatory diseases and neurodegeneration.
Promiscuity and selectivity in covalent enzyme inhibition: A systematic study of electrophilic fragments
J?st, Christian,Nitsche, Christoph,Scholz, Therese,Roux, Lionel,Klein, Christian D.
supporting information, p. 7590 - 7599 (2014/12/11)
Covalent ligand-target interactions offer significant pharmacological advantages. However, off-target reactivity of the reactive groups, which usually have electrophilic properties, must be minimized, and the selectivity of irreversible inhibitors is a crucial requirement. We therefore performed a systematic study to determine the selectivity of several electrophilic groups that can be used as building blocks for covalently binding ligands. Six reactive groups with modulated electrophilicity were combined with 11 nonreactive moieties, resulting in a small combinatorial library of 72 fragment-like compounds. These compounds were screened against a group of 11 enzyme targets to assess their selectivity and their potential for promiscuous binding to proteins. The assay results showed a considerably lower degree of promiscuity than initially expected, even for those members of the screening collection that contain supposedly highly reactive electrophiles.
Discovery and structure-activity relationships of small molecules that block the human immunoglobulin G-human neonatal Fc receptor (hIgG-hFcRn) protein-protein interaction
Wang, Zhaolin,Fraley, Cara,Mezo, Adam R.
, p. 1253 - 1256 (2013/03/14)
The neonatal Fc receptor, FcRn, prolongs the half-life of IgG in the serum and represents a potential therapeutic target for the treatment of autoimmune disease. Small molecules that block the protein-protein interactions of human IgG-human FcRn may lower pathogenic autoantibodies and provide effective treatment. A novel class of quinoxalines has been discovered as antagonists of the IgG:FcRn protein-protein interaction through optimization of a hit derived from a virtual ligand-based screen.
Design, synthesis, and binding mode prediction of 2-pyridone-based selective CB2 receptor agonists
Kusakabe, Ken-Ichi,Tada, Yukio,Iso, Yasuyoshi,Sakagami, Masahiro,Morioka, Yasuhide,Chomei, Nobuo,Shinonome, Satomi,Kawamoto, Keiko,Takenaka, Hideyuki,Yasui, Kiyoshi,Hamana, Hiroshi,Hanasaki, Kohji
, p. 2045 - 2055 (2013/04/24)
Selective CB2 agonists have the potential for treating pain without central CB1-mediated adverse effects. Screening efforts identified 1,2-dihydro-3- isoquinolone 1; however, this compound has the drawbacks of being difficult to synthesize with two asymme
A class of 5-nitro-2-furancarboxylamides with potent trypanocidal activity against Trypanosoma brucei in vitro
Zhou, Linna,Stewart, Gavin,Rideau, Emeline,Westwood, Nicholas J.,Smith, Terry K.
supporting information, p. 796 - 806 (2013/03/28)
Recently, the World Health Organization approved the nifurtimox- eflornithine combination therapy for the treatment of human African trypanosomiasis, renewing interest in nitroheterocycle therapies for this and associated diseases. In this study, we have synthesized a series of novel 5-nitro-2-furancarboxylamides that show potent trypanocidal activity, ～1000-fold more potent than nifurtimox against in vitro Trypanosoma brucei with very low cytotoxicity against human HeLa cells. More importantly, the most potent analogue showed very limited cross-resistance to nifurtimox-resistant cells and vice versa. This implies that our novel, relatively easy to synthesize and therefore cheap, 5-nitro-2-furancarboxylamides are targeting a different, but still essential, biochemical process to those targeted by nifurtimox or its metabolites in the parasites. The significant increase in potency (smaller dose probably required) has the potential for greatly reducing unwanted side effects and also reducing the likelihood of drug resistance. Collectively, these findings have important implications for the future therapeutic treatment of African sleeping sickness.
Development and SAR of functionally selective allosteric modulators of GABAA receptors
Alhambra, Cristobal,Becker, Chris,Blake, Timothy,Chang, Amy,Damewood Jr., James R.,Daniels, Thalia,Dembofsky, Bruce T.,Gurley, David A.,Hall, James E.,Herzog, Keith J.,Horchler, Carey L.,Ohnmacht, Cyrus J.,Schmiesing, Richard Jon,Dudley, Adam,Ribadeneira, Maria D.,Knappenberger, Katherine S.,MacIag, Carla,Stein, Mark M.,Chopra, Maninder,Liu, Xiaodong F.,Christian, Edward P.,Arriza, Jeffrey L.,Chapdelaine, Marc J.
experimental part, p. 2927 - 2938 (2011/06/21)
Positive modulators at the benzodiazepine site of α2- and α3-containing GABAA receptors are believed to be anxiolytic. Through oocyte voltage clamp studies, we have discovered two series of compounds that are positive modulators at α2-/α3-containing GABAA receptors and that show no functional activity at α1-containing GABA A receptors. We report studies to improve this functional selectivity and ultimately deliver clinical candidates. The functional SAR of cinnolines and quinolines that are positive allosteric modulators of the α2- and α3-containing GABAA receptors, while simultaneously neutral antagonists at α1-containing GABAA receptors, is described. Such functionally selective modulators of GABAA receptors are expected to be useful in the treatment of anxiety and other psychiatric illnesses.
